Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Control of Prostatic Cancer With Criteria of Latence. Impact on Specific 10 Years Survival.

NCT00921258 is registered in ClinicalTrials.gov with Clinique Mutualiste Chirurgicale de la Loire as lead sponsor.

NCT NCT00921258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00921258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Control of Prostatic Cancer With Criteria of Latence. Impact on Specific 10 Years Survival.
Lead sponsor
Clinique Mutualiste Chirurgicale de la Loire
Phase
Observational
Overall status
Terminated
Start date
December 31, 2007
Completion date
December 31, 2013
Enrollment
100 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer